{"id":7635,"date":"2021-01-13T00:00:00","date_gmt":"2021-01-13T00:00:00","guid":{"rendered":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2021\/01\/13\/treatment-plans-outcomes-better-for-women-with-acs-and-low-risk-heart-score\/"},"modified":"2021-01-14T18:10:25","modified_gmt":"2021-01-14T18:10:25","slug":"treatment-plans-outcomes-better-for-women-with-acs-and-low-risk-heart-score","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2021\/01\/13\/treatment-plans-outcomes-better-for-women-with-acs-and-low-risk-heart-score\/","title":{"rendered":"Treatment Plans, Outcomes Better for Women With ACS and Low-Risk HEART Score"},"content":{"rendered":"<h3>\n<p>Women may receive more appropriate care than men with use of History, Electrocardiogram, Age, Risk factors, and Troponin (HEART) score<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>WEDNESDAY, Jan. 13, 2021 (HealthDay News) &#8212; Women with suspected acute coronary syndrome who have low-risk History, Electrocardiogram, Age, Risk factors, and Troponin (HEART) scores have more appropriate testing and better outcomes than men, according to a study published online Dec. 23 in the <em>Annals of Emergency Medicine.<\/em><\/p>\n<p>Salena M. Preciado, from Kaiser Permanente Southern California in Pasadena, and colleagues analyzed 34,715 adult emergency department encounters evaluated for suspected acute coronary syndrome with a documented HEART score (56 percent women).<\/p>\n<p>The researchers found that more women were classified as low risk (60.5 versus 52.4 percent; odds ratio [OR], 1.39; 95 percent confidence interval [CI], 1.33 to 1.45). Compared with men, women were hospitalized or received stress testing less often for low HEART scores (18.8 versus 22.8 percent; OR, 0.79; 95 percent CI, 0.73 to 0.84) and intermediate HEART scores (46.7 versus 49.7 percent; OR, 0.88; 95 percent CI, 0.83 to 0.95), but these percentages were similar for women and men with high HEART scores (74.1 versus 74.4 percent; OR, 0.99; 95 percent CI, 0.77 to 1.28). Even after adjustment for HEART score and comorbidities, women had lower odds of hospitalization or noninvasive cardiac testing (OR, 0.82; 95 percent CI, 0.78 to 0.86). For all HEART score categories, men had a higher risk for major adverse cardiac events than women, with a significantly higher risk for low-risk HEART scores (0.4 versus 0.1 percent).<\/p>\n<p>&#8220;We found after implementation of the HEART score that women received more appropriate care than men with physicians less likely to recommend low-value cardiac testing for lower and intermediate risk levels, and comparable care for those at high risk,&#8221; a coauthor said in a statement.<\/p>\n<p><a href=\"https:\/\/www.annemergmed.com\/article\/S0196-0644(20)31353-6\/fulltext\" rel=\"noopener noreferrer\" target=\"_blank\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Women may receive more appropriate care than men with use of History, Electrocardiogram, Age, Risk factors, and Troponin (HEART) score<\/p>\n","protected":false},"author":4,"featured_media":7831,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[85],"tags":[251,239,366],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/7635"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=7635"}],"version-history":[{"count":0,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/7635\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media\/7831"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=7635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=7635"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=7635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}